Orthocell Limited (OCC) is engaged in the development and commercialization of novel collagen medical devices and cellular therapies for the repair and regeneration of human tendons, bone, nerve and cartilage defects. It has a Good Manufacturing Process (GMP) facility in place for quality control and also holds an ISO certification for the manufacture of its products such as CelGro. The company’s predominant place of operation is in Australia.
Orthocell Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.orthocell.com.au.
This a small cap company with market cap of 97 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.
Dividend Growth Chart
The following chart shows you how occ dividend grows in the recent years.